Cited by 109Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMultiple Sclerosis Research Studies

Apolipoprotein E Affects Both Myelin Breakdown and Cognition: Implications for Age-Related Trajectories of Decline Into Dementia

Bartzokis, George, Lu, Po H., Geschwind, Daniel H., Tingus, Kathleen, Huang, Danny, Mendez, Mario F., Edwards, Nancy, Mintz, Jim·2007·Biological Psychiatry

Abstract

Background Age-related myelin breakdown is most evident in later-myelinating white matter (LMwm) brain regions. This process might degrade cognitive processing speed (CPS) underlying age-related cognitive decline and the predominance of age as a risk factor for Alzheimer's disease (AD). Apolipoprotein E (ApoE) 4 allele is the second most important AD risk factor. We tested the hypothesis that ApoE4 accelerates age-related slowing in CPS through the process of myelin breakdown. Methods Calculated transverse relaxation rates (R(2)), an indirect magnetic resonance imaging measure of myelin breakdown in LMwm, and measures of CPS were obtained in 22 ApoE4+ and 80 ApoE4-, healthy "younger-old" individuals. To assess specificity, contrasting early-myelinating white matter region and memory task were also examined. Results The CPS versus LMwm R(2) remained significant in the ApoE4+ group even after age was statistically adjusted (r = .65, p = .001) and differed from the correlation observed in the ApoE4- group (Fisher's z test = 3.22, p < .002). No significant associations were observed with the contrast region and memory task in either ApoE subgroup. Conclusions A specific association between CPS and myelin breakdown in LMwm exists in asymptomatic "younger-old" individuals at increased genetic risk for AD. Although inferences of change over time and causality are limited by the cross-sectional study design, this finding lends support to the hypotheses that myelin breakdown underlies age-related slowing in CPS and that by altering the trajectory of myelin breakdown, ApoE alleles shift the age at onset of cognitive decline. Combined use of biomarkers and CPS measures might be useful in developing and targeting primary prevention treatments for AD.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2007.03.024

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bartzokis, G., Lu, P. H., Geschwind, D. H., Tingus, K., Huang, D., Mendez, M. F., Edwards, N., & Mintz, J.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Bartzokis, George
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2007-12
Volume
62
Issue
12
Pages
1380-1387
ISSN
0006-3223 (ISSN-L)
OpenAlex
W1964634864
Cited by
109
References
13
Citations by year
2026: 3 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 5 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 8 · 2013: 8 · 2012: 11
FWCI
4.21
Type
journal article
Language
en
Open access
closed
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (R01AG027342, P50AG016570)
  • National Institute of Mental Health (MH6357-01A1, MH 51928, MH066029-01A2, R01MH066029, R03MH051928)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
Keywords
apolipoprotein E, APOE ε4, myelin breakdown, processing speed, age-related cognitive decline, Alzheimer's disease risk, transverse relaxation rate, dementia prevention, white matter aging
MeSH terms
Aged, Aged, 80 and over, Aging, Apolipoproteins E, Cognition Disorders, Dementia, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Myelin Sheath, Neuropsychological Tests, Chi-Square Distribution, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review